STK39 and breast carcinoma: To verify whether women with primary breast cancers that express a high level of STK39 relapse at a faster rate than women whose breast cancers express a low level of STK39, in a pattern similar to that of SNAI1, we analyzed two microarray expression datasets derived from primary human breast cancers in which both STK39 expression level and clinical outcome were available.